Registry of Patients Having Vein Blocking Procedures Before Liver Cancer Surgery
Collects data on people with liver tumors who had combined vein embolization before surgery.
Key facts
- Who runs it
- Maastricht University Medical Center
- Where
- Zurich, SwitzerlandSee the siteAlso in 12 other countries, 30 sites
- Trial code
- Registry title
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 16 Mar 2021
- Expected to end
- 30 Nov 2032
- Type of study
- Observational
- Record updated
- 21 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults who have had combined portal and hepatic vein embolization (PVE/HVE), or a similar variation of it, for liver cancer or liver metastases.
- Age
- 18 years and older
- Sex
- Men and women can join.
- Disease stage
- Liver cancer or liver metastases that could not be removed by surgery at first (from the trial title).
- Earlier treatment
- People must have had PVE/HVE or a technical variation of this procedure.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients who have undergone PVE/HVE or technical variations on this procedure
- 18 Years and older
- Men and women
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you 18 years old or older?
- Are you planning to have, or have you had, an operation to remove part of your liver?
- Has a doctor told you that the part of your liver that would be left after surgery may be too small?
Where in Switzerland
Also in 12 other countries, 30 sites
- Klinik HirslandenZurich, SwitzerlandContact: Erik Schadde, Dr.Taking people
About the trial
What the trial wants to find out
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
The group in the trial
- PVE/HVE
This registry collects data on patients who have undergone combined portal and hepatic vein embolisation prior to major liver surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Plain-language title
- Registry of Patients Having Vein Blocking Procedures Before Liver Cancer SurgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07717437, who can take part
- Record updated
- 21 July 2026